282 related articles for article (PubMed ID: 16261289)
1. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.
Almawi WY; Keleshian SH; Borgi L; Fawaz NA; Abboud N; Mtiraoui N; Mahjoub T
J Thromb Thrombolysis; 2005 Dec; 20(3):163-8. PubMed ID: 16261289
[TBL] [Abstract][Full Text] [Related]
2. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon.
Bouaziz-Borgi L; Almawi WY; Mtiraoui N; Nsiri B; Keleshian SH; Kreidy R; Louzir B; Hezard N; Mahjoub T
Am J Hematol; 2006 Aug; 81(8):641-3. PubMed ID: 16823828
[TBL] [Abstract][Full Text] [Related]
3. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
[TBL] [Abstract][Full Text] [Related]
5. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
[TBL] [Abstract][Full Text] [Related]
9. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
[TBL] [Abstract][Full Text] [Related]
10. Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus.
Wakim-Ghorayeb SF; Keleshian SH; Timson G; Finan RR; Najm P; Irani-Hakime N; Almawi WY
Am J Hematol; 2005 Sep; 80(1):84-6. PubMed ID: 16138347
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.
Mtiraoui N; Borgi L; Hizem S; Nsiri B; Finan RR; Gris JC; Almawi WY; Mahjoub T
Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):164-70. PubMed ID: 15808373
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.
Dajani R; Fatahallah R; Dajani A; Al-Shboul M; Khader Y
Mol Biol Rep; 2012 Sep; 39(9):9133-8. PubMed ID: 22744422
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
Bagheri M; Rad IA; Nanbakhsh F
Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
[TBL] [Abstract][Full Text] [Related]
15. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
Martinelli I; Battaglioli T; Razzari C; Mannucci PM
J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
[TBL] [Abstract][Full Text] [Related]
16. [Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain].
Francès F; Portolès O; Gabriel F; Corella D; Sorlí JV; Sabater A; Alfonso JL; Guillén M
Rev Med Chil; 2006 Jan; 134(1):13-20. PubMed ID: 16532157
[TBL] [Abstract][Full Text] [Related]
17. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.
Angchaisuksiri P; Pingsuthiwong S; Aryuchai K; Busabaratana M; Sura T; Atichartakarn V; Sritara P
Am J Hematol; 2000 Oct; 65(2):119-22. PubMed ID: 10996828
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
20. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
Huber S; McMaster KJ; Voelkerding KV
J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
